Identification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family*
- Eliahu Golombद,
- Xuefei Ma‡,
- Siddhartha S. Jana‡,
- Yvette A. Preston‡,
- Sachiyo Kawamoto‡,
- Nitza G. Shoham∥,
- Ehud Goldin**,
- Mary Anne Conti‡,
- James R. Sellers‡ and
- Robert S. Adelstein‡
- ‡Laboratory of Molecular Cardiology, NHLBI, the ∥Genetics and Genomics Branch, NIAMS, and the **Developmental Metabolic Neurology Branch, NINDS, National Institutes of Health, Bethesda, Maryland 20892 and the §Department of Pathology, Shaare Zedek Medical Center, Jerusalem 91031, Israel
- ↵¶ To whom correspondence should be addressed: Dept. of Pathology, Shaare Zedek Medical Center, Jerusalem 91031, Israel. E-mail: golomb{at}szmc.org.il.
Abstract
A previously unrecognized nonmuscle myosin II heavy chain (NMHC II), which constitutes a distinct branch of the nonmuscle/smooth muscle myosin II family, has recently been revealed in genome data bases. We characterized the biochemical properties and expression patterns of this myosin. Using nucleotide probes and affinity-purified antibodies, we found that the distribution of NMHC II-C mRNA and protein (MYH14) is widespread in human and mouse organs but is quantitatively and qualitatively distinct from NMHC II-A and II-B. In contrast to NMHC II-A and II-B, the mRNA level in human fetal tissues is substantially lower than in adult tissues. Immunofluorescence microscopy showed distinct patterns of expression for all three NMHC isoforms. NMHC II-C contains an alternatively spliced exon of 24 nucleotides in loop I at a location analogous to where a spliced exon appears in NMHC II-B and in the smooth muscle myosin heavy chain. However, unlike neuron-specific expression of the NMHC II-B insert, the NMHC II-C inserted isoform has widespread tissue distribution. Baculovirus expression of noninserted and inserted NMHC II-C heavy meromyosin (HMM II-C/HMM II-C1) resulted in significant quantities of expressed protein (mg of protein) for HMM II-C1 but not for HMM II-C. Functional characterization of HMM II-C1 by actin-activated MgATPase activity demonstrated a Vmax of 0.55 + 0.18 s–1, which was half-maximally activated at an actin concentration of 16.5 + 7.2 μm. HMM II-C1 translocated actin filaments at a rate of 0.05 + 0.011 μm/s in the absence of tropomyosin and at 0.072 + 0.019 μm/s in the presence of tropomyosin in an in vitro motility assay.
- Received September 8, 2003.
- Revision received October 20, 2003.
- The American Society for Biochemistry and Molecular Biology, Inc.











